•
Spock’s Brain – now in production at Google
Talks about Machine Learning, Google and Datacenter
VP
Vijay Pande
General Partner at Andreessen Horowitz
San Francisco Bay Area
Overview
Vijay Pande is the Founder & Managing Partner of a16z BioHealth, with a background in computational biology and bioinformatics. He has served as a General Partner at Andreessen Horowitz and invested in various successful companies, such as Devoted Health and BioAge Labs.
Pande's career highlights include his role as a Professor In Residence/Distinguished Visiting Professor of Computer Science and his investments in companies like Elegen and Genesis Therapeutics, showcasing his expertise in the biotech and health sectors.
Work Experience
General Partner
2015 - Current
Dr. Pande is a General Partner at Andreessen Horowitz, where he leads the firm’s investments focused on the cross section of biology and computer science including areas such as digital therapeutics, cloud biology, and computational medicine.
Professor In Residence/Distinguished Visiting Professor of Computer Science
2014 - 2015
In my role as Professor In Residence, I worked with facilitating deals, especially those with technical elements in Biology and Medicine as well as those sourcing from academia.
Andreessen Horowitz is a stage-agnostic venture capital firm with assets under management across multiple funds.
Member Board Of Directors
2018
Insitro is a drug discovery and development startup that utilizes machine learning and biology to transform drug discovery.
Raised $643,000,000.00 from Alexandria Venture Investments, BlackRock, HOF Capital, CPP Investments, Google Ventures, Foresite Capital, Casdin Capital, Temasek Holdings, T. Rowe Price and Third Rock Ventures.
Member Board Of Directors
2018
Devoted Health is a healthcare company serving seniors and giving them a health care plan with personal guides and world-class technology.
Raised $2,256,000,000.00 from White Road Investments, Cox Enterprises, The Space Between, F-Prime Capital, Emerson Collective, GreatPoint Ventures, The Space Between, Stardust Equity, Fearless Ventures and The Private Shares Fund.
Member Board Of Directors
2016
Apeel Sciences develops plant-derived shelf life extension technology for fresh produce that improves quality and reduces food waste.
Raised $719,060,564.00 from Redbadge Pacific and KAAN Ventures.
Member Board Of Directors
2018
Nautilus Biotechnology offers a high-throughput, low-cost platform for analyzing and quantifying the human proteome.
Raised $303,200,000.00 from Ally Bridge Group, Andreessen Horowitz, Alyeska Investment Group, Casdin Capital, Perceptive Advisors, OrbiMed, Madrona, RA Capital Management, Franklin Templeton and Vulcan Capital.
Member Board Of Directors
2017
Freenome is a biotechnology company with a comprehensive multiomics platform for cancer detection using a routine blood draw.
Raised $1,351,550,000.00 from BrightEdge Fund, T. Rowe Price, ArrowMark Partners, Roche, Section 32, Sands Capital Ventures, Artis Ventures (AV), Andreessen Horowitz, ARK Investment Management and Pura Vida Investments.
Investor and Advisor
2018
Bayesian Health is an adaptive AI platform that offers health systems through clinical AI.
Raised $15,225,000.00 from Andreessen Horowitz, Health2047 Capital Partners, Lifeforce Capital and Catalio Capital Management.
Member Board Of Directors
2019
Member Board Of Directors
2018
Member Board Of Directors
2018
Scribe Therapeutics is a biotech company that develops and engineers new therapeutics based on CRISPR molecules.
Raised $120,000,000.00 from Prevail Therapeutics.